Cargando…

Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model

The ongoing COVID-19 pandemic highlights the urgent need for effective antiviral agents and vaccines. Drug repositioning, which involves modifying existing drugs, offers a promising approach for expediting the development of novel therapeutics. In this study, we developed a new drug, MDB-MDB-601a-NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Ju Hwan, Lee, Woong Hee, Min, Seong Cheol, Kim, Beom Kyu, Park, On Bi, Chokkakula, Santosh, Ahn, Seong Ju, Oh, Sol, Park, Ji-Hyun, Jung, Ji Won, Jung, Ji Min, Kim, Eung-Gook, Song, Min-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253381/ https://www.ncbi.nlm.nih.gov/pubmed/37298530 http://dx.doi.org/10.3390/ijms24119579

Ejemplares similares

Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment
por: Han, Sung Joon, et al.
Publicado: (2018)

Cardiac arrest caused by nafamostat mesilate
por: Kim, Hyo Shik, et al.
Publicado: (2016)

The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
por: Kim, Joo Seong, et al.
Publicado: (2022)

Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
por: Jeong, Ju Hwan, et al.
Publicado: (2022)

Nafamostat Mesilate: Can It Be Used as a Conduit Preserving Agent in Coronary Artery Bypass Surgery?
por: Yoon, Yoo Sang, et al.
Publicado: (2013)

Co-Spray Dried Nafamostat Mesylate with Lecithin and Mannitol as Respirable Microparticles for Targeted Pulmonary Delivery: Pharmacokinetics and Lung Distribution in Rats
por: Kang, Ji-Hyun, et al.
Publicado: (2021)

Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
por: Batool, Sania, et al.
Publicado: (2023)

Heparin/nafamostat: Bleeding and subcutaneous haematoma: case report
Publicado: (2022)

Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis
por: Kim, Joo-Hee, et al.
Publicado: (2021)

Nafamostat Mesilate Inhibits TNF-α-Induced Vascular Endothelial Cell Dysfunction by Inhibiting Reactive Oxygen Species Production
por: Kang, Min-Woong, et al.
Publicado: (2015)

A Rapid Method for Generating Infectious SARS-CoV-2 and Variants Using Mutagenesis and Circular Polymerase Extension Cloning
por: Kim, Beom Kyu, et al.
Publicado: (2023)

Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial
por: Choi, Ji-Young, et al.
Publicado: (2015)

Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in Mice
por: Ban, Ju Yeon, et al.
Publicado: (2020)

Subcutaneous Panniculitis-Like T-Cell Lymphoma of the Breast
por: Jeong, Seo In, et al.
Publicado: (2013)

Nafamostat mesilate promotes endothelium-dependent vasorelaxation via the Akt-eNOS dependent pathway
por: Choi, Sujeong, et al.
Publicado: (2016)

A Case of Subcutaneous Hemangioma Presenting as a Preauricular Sinus
por: Jin, Sang-Gyun, et al.
Publicado: (2013)

Development of a Universal Cloning System for Reverse Genetics of Human Enteroviruses
por: Choi, Won-Suk, et al.
Publicado: (2023)

The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation
por: Lee, Jae Ha, et al.
Publicado: (2022)

Synthesis and antiviral activity of 18α-glycyrrhizic acid and its esters
por: Baltina, L. A., et al.
Publicado: (2010)

Synthesis of Glycyrrhizic Acid Conjugates with S-Benzyl-L-Cysteine and Their Antiviral Activity
por: Baltina, L. A., et al.
Publicado: (2021)

Synthesis, Antiviral, and Antibacterial Activity of the Glycyrrhizic Acid and Glycyrrhetinic Acid Derivatives
por: Mohammed, E. A. H., et al.
Publicado: (2022)

Physiologically-based pharmacokinetic modeling of nafamostat to support dose selection for treatment of pediatric patients with COVID-19
por: Cho, Yong-Soon, et al.
Publicado: (2022)

Pneumoretroperitoneum, Pneumomediastinum, Subcutaneous Emphysema After a Rectal Endoscopic Mucosal Resection
por: Jung, Hee Cheul, et al.
Publicado: (2016)

Amelioration of Mouse Retinal Degeneration After Blue LED Exposure by Glycyrrhizic Acid-Mediated Inhibition of Inflammation
por: Kim, Gyu Hyun, et al.
Publicado: (2019)

Formulation of Glycyrrhizic Acid-based Nanocomplexes for Enhanced Anti-cancer and Anti-inflammatory Effects of Curcumin
por: Song, Jihyeon, et al.
Publicado: (2022)

Broad Antiviral Spectrum of Glycyrrhizic Acid for Human and Veterinary Medicine: Reality or Fiction?
por: García-Salazar, Gilberto, et al.
Publicado: (2022)

Crystal structure of nafamostat dimesylate
por: Fujii, Isao
Publicado: (2021)

Nafamostat: Hyperkalaemia: case report
Publicado: (2021)

Formulation and in vitro/in vivo evaluation of chitosan-based film forming gel containing ketoprofen
por: Oh, Dong-Won, et al.
Publicado: (2017)

Anti-Inflammatory Activities of Licorice Extract and Its Active Compounds, Glycyrrhizic Acid, Liquiritin and Liquiritigenin, in BV2 Cells and Mice Liver
por: Yu, Ji-Yeon, et al.
Publicado: (2015)

Anther Culture-Derived Haploids of Citrus aurantium L. (Sour Orange) and Genetic Verification of Haploid-Derived Regenerated Plants
por: Jin, Seong Beom, et al.
Publicado: (2022)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

Synthesis and antiviral activity of novel glycyrrhizic acid conjugates with D-amino acid esters
por: Fayrushina, A. I., et al.
Publicado: (2017)

A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
por: Zuo, Jiawei, et al.
Publicado: (2023)

A case of generalized argyria presenting with muscle weakness
por: Jung, Inha, et al.
Publicado: (2017)

Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate
por: Chang, Jae Hyuck, et al.
Publicado: (2009)

Development of Molecular Marker to Detect Citrus Melanose Caused by Diaporthe citri from Citrus Melanose-like Symptoms
por: Choi, Cheol-Woo, et al.
Publicado: (2021)

Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: A timing challenge for clinicians
por: Ji, Hong-Long, et al.
Publicado: (2021)

Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
por: Gao, Lili, et al.
Publicado: (2015)

Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
por: Jang, Sukbin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_547iejiqf794g9c6031fl2pufg